It's the first study to demonstrate cardiovascular risks of high doses of ketamine (low blood pressure, arrhythmia), side effects that have not been well studied in the past.

Vanderbilt-Ingram Cancer Center accrued the most patients nationwide for the clinical trial for P-BCMA-ALLO1 – a chimeric antigen receptor T cell therapy (CAR-T) derived from healthy donors’ white blood cells.

In a large, placebo-controlled, randomized trial, the pain reliever ketamine posed side effects while failing to aid patient recovery after major surgery.

Researchers hope to slow the progression of this chronic eye disease that affects approximately 40% of the U.S. population.

Risk of VTE rises in hospitals due to factors such as patient immobility, effects from major surgery, and use of indwelling medical devices like central lines.

The team used an artificial tricuspid valve, EVOQUE, which received Food and Drug Administration approval in February.

The VUMC approach, based on the “Feeling Safe Program” developed by British psychologist Daniel Freeman, targets specific factors that contribute to persecutory delusions, including worry, safety behaviors, avoidance and hallucinations (such as hearing voices).